Robeco Institutional Asset Management B.V. Decreases Holdings in Cencora, Inc. $COR

Robeco Institutional Asset Management B.V. cut its holdings in shares of Cencora, Inc. (NYSE:COR) by 28.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 141,449 shares of the company’s stock after selling 57,609 shares during the quarter. Robeco Institutional Asset Management B.V. owned approximately 0.07% of Cencora worth $47,774,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. IAG Wealth Partners LLC purchased a new stake in Cencora in the 3rd quarter worth about $30,000. Cloud Capital Management LLC purchased a new stake in Cencora in the 3rd quarter worth about $31,000. Caitlin John LLC purchased a new stake in Cencora in the 3rd quarter worth about $31,000. Westside Investment Management Inc. boosted its stake in Cencora by 200.0% in the 3rd quarter. Westside Investment Management Inc. now owns 105 shares of the company’s stock worth $33,000 after purchasing an additional 70 shares during the period. Finally, Harbor Investment Advisory LLC purchased a new position in Cencora during the 4th quarter valued at about $35,000. 97.52% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Cencora

In other news, CEO Robert P. Mauch sold 5,096 shares of the business’s stock in a transaction dated Tuesday, January 20th. The stock was sold at an average price of $354.73, for a total transaction of $1,807,704.08. Following the completion of the transaction, the chief executive officer owned 66,726 shares of the company’s stock, valued at approximately $23,669,713.98. The trade was a 7.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.38% of the company’s stock.

Cencora Stock Down 0.6%

COR stock opened at $318.96 on Tuesday. The firm has a market capitalization of $62.05 billion, a PE ratio of 38.34, a PEG ratio of 1.50 and a beta of 0.72. The company has a quick ratio of 0.51, a current ratio of 0.92 and a debt-to-equity ratio of 3.62. The stock has a 50-day simple moving average of $344.46 and a two-hundred day simple moving average of $342.97. Cencora, Inc. has a twelve month low of $271.00 and a twelve month high of $377.54.

Cencora (NYSE:COR) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 EPS for the quarter, topping the consensus estimate of $4.04 by $0.04. Cencora had a return on equity of 176.54% and a net margin of 0.50%.The company had revenue of $85.93 billion during the quarter, compared to analyst estimates of $86.12 billion. During the same quarter in the previous year, the firm earned $3.73 earnings per share. Cencora’s revenue was up 5.5% on a year-over-year basis. On average, equities analysts predict that Cencora, Inc. will post 15.37 EPS for the current fiscal year.

Cencora Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were issued a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, February 13th. This represents a $2.40 annualized dividend and a dividend yield of 0.8%. Cencora’s payout ratio is presently 28.85%.

Analysts Set New Price Targets

A number of research analysts have weighed in on the company. Bank of America reduced their target price on Cencora from $380.00 to $360.00 and set a “neutral” rating for the company in a report on Monday, January 5th. Weiss Ratings raised Cencora from a “hold (c+)” rating to a “buy (b)” rating in a report on Thursday, February 5th. Morgan Stanley set a $380.00 target price on Cencora in a report on Tuesday, March 17th. Barclays lifted their target price on Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a report on Friday, February 13th. Finally, Wells Fargo & Company lifted their target price on Cencora from $405.00 to $429.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. Twelve analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $398.17.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.